摘要
经皮冠脉内介入治疗(PCI)目前已成为冠心病的重要治疗方式。但是,术后发生的支架内再狭窄(ISR)及晚期的血栓形成(LST)是当前临床上亟待解决的问题。研究发现,支架内新生动脉粥样硬化(ISNA)是造成ISR及LST的重要原因。对于ISNA的预防和治疗是当前提高冠脉内支架远期效果的切入点。本文主要针对支架内新生动脉粥样硬化的病理机制及其中西医的防治进行论述。
Percutaneous coronary intervention has become the important means on the therapy of coronary heart disease. But, the current clinical problems solved are postoperative restenosis and late stent thrombos is which can cause serious adverse cardiovascular events. Studies have found that in-stent neoatherosclosis is an important reason of ISR and LST. For the prevention and treatment of ISNA is the entry point to improve the long-term effect of coronary stent at present. In this paper, the pathogenesis of neonatal atherosclerosis and the prevention and treatment of Chinese and western medicine were discussed.
作者
李丹云
王贺
司春婴
罗明华
陈玉善
关怀敏
LI Danyun WANG He SI Chunying LUO Minghua CHEN Yushan GUAN Huaimin(The Graduate School, He＇nan University of Chinese Medicine, He＇nan Province, Zhengzhou 450000, China Heart Center, First Affiliated Hospital of He＇nan University of Chinese Medicine, He＇nan Province, Zhengzhou 450000, China)
出处
《中国医药导报》
CAS
2017年第22期47-50,共4页
China Medical Herald
基金
国家自然科学基金资助项目(81473507)
关键词
冠心病
支架内新生动脉粥样硬化
中西医
研究
Coronary artery disease
In-stent neoatherosclerosis
Chinese and western medicine
Research
